Prediction of cardiovascular risk factors from retinal fundus photographs: Validation of a deep learning algorithm in a prospective non‐interventional study in Kenya

Author:

White Tom1,Selvarajah Viknesh2ORCID,Wolfhagen‐Sand Fredrik2ORCID,Svangård Nils3,Mohankumar Gayathri4,Fenici Peter567,Rough Kathryn8,Onyango Nelson8,Lyons Kendall8,Mack Christina8,Nduba Videlis9,Noorali Saleh Mansoor10,Abayo Innocent10,Siddiqui Afrah11,Majdanska‐Strzalka Malgorzata12,Kaszubska Katarzyna12,Hegelund‐Myrback Tove13,Esterline Russell14,Manzur Antonio2,Parker Victoria E. R.2ORCID

Affiliation:

1. Data Science and Advanced Analytics Data Science & Artificial Intelligence, R&D, AstraZeneca Cambridge UK

2. Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM) BioPharmaceuticals R&D, AstraZeneca Cambridge UK

3. Data Science and Advanced Analytics Data Science & Artificial Intelligence, R&D, AstraZeneca Gothenburg Sweden

4. Centre for Artificial Intelligence Data Science & Artificial Intelligence, R&D, AstraZeneca Gaithersburg Maryland USA

5. School of Medicine and Surgery Catholic University Rome Italy

6. Biomagnetism and Clinical Physiology International Center (BACPIC) Rome Italy

7. AstraZeneca, Medical Affairs, BioPharmaceuticals, AstraZeneca Milan Italy

8. IQVIA Durham North Carolina USA

9. Kenya Medical Research Institute Nairobi Kenya

10. Clinical Research Unit Aga Khan University Hospital Nairobi Kenya

11. BioPharmaceuticals Medical AstraZeneca Cambridge UK

12. CVRM Clinical Operations, Biopharmaceuticals R&D, AstraZeneca Warsaw Poland

13. Global Portfolio & Project Management Early CVRM&NS, R&D, AstraZeneca Gothenburg Sweden

14. Research and Late Development, Cardiovascular, Renal and Metabolism (CVRM) BioPharmaceuticals R&D, AstraZeneca Gaithersburg USA

Abstract

AbstractAimHypertension and diabetes mellitus (DM) are major causes of morbidity and mortality, with growing burdens in low‐income countries where they are underdiagnosed and undertreated. Advances in machine learning may provide opportunities to enhance diagnostics in settings with limited medical infrastructure.Materials and MethodsA non‐interventional study was conducted to develop and validate a machine learning algorithm to estimate cardiovascular clinical and laboratory parameters. At two sites in Kenya, digital retinal fundus photographs were collected alongside blood pressure (BP), laboratory measures and medical history. The performance of machine learning models, originally trained using data from the UK Biobank, were evaluated for their ability to estimate BP, glycated haemoglobin, estimated glomerular filtration rate and diagnoses from fundus images.ResultsIn total, 301 participants were enrolled. Compared with the UK Biobank population used for algorithm development, participants from Kenya were younger and would probably report Black/African ethnicity, with a higher body mass index and prevalence of DM and hypertension. The mean absolute error was comparable or slightly greater for systolic BP, diastolic BP, glycated haemoglobin and estimated glomerular filtration rate. The model trained to identify DM had an area under the receiver operating curve of 0.762 (0.818 in the UK Biobank) and the hypertension model had an area under the receiver operating curve of 0.765 (0.738 in the UK Biobank).ConclusionsIn a Kenyan population, machine learning models estimated cardiovascular parameters with comparable or slightly lower accuracy than in the population where they were trained, suggesting model recalibration may be appropriate. This study represents an incremental step toward leveraging machine learning to make early cardiovascular screening more accessible, particularly in resource‐limited settings.

Funder

AstraZeneca

Publisher

Wiley

Reference35 articles.

1. World Health Organization.The top 10 causes of death.2020Accessed February 21 2022.https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death

2. World Health Organization.Global Health Estimates.2019Accessed February 21 2022.https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death

3. World Health Organization.More than 700 million people with untreated hypertension.2021.

4. Clinical challenges in diagnosing and managing adult hypertension

5. World Health Organization.Global report on diabetes. WHO library cataloguing‐in‐publication data global report on diabetes.2016.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3